Biological E.

“Neglected” is not inevitable. It’s a choice. At The World Vaccine Congress 2026 I had the opportunity to join a panel on Neglected Tropical Diseases, “Chikungunya & mosquito‑borne vaccines — and one reality stood out clearly. Vaccine is ready. Manufacturing capacity exists. Yet when outbreaks strike, we are still not ready to deliver at scale. This is not a technical failure — it’s a systemic one. From our experience at Biological E. Limited , we know that vaccines move from capacity to impact only when early alignment, clear demand signals, and ecosystem coordination come together. For #Chikungunya , the path forward is clear: Align development, manufacturing, and access early Build scalable, cost‑efficient capacity before demand Strengthen real‑world evidence Create predictable, sustainable procurement pathways Manufacturers are ready to be partners in access, not just suppliers. But without clear prioritization, even the strongest manufacturing base falls short. Leadership from Gavi, the Vaccine Alliance and the World Health Organization will be critical to move Chikungunya from the margins to a true global health priority. The opportunity is here — let’s choose differently before the next outbreak chooses us. #Vaccines #GlobalHealth #Chikungunya #NTDs #PandemicPreparedness #Manufacturing #AccessToVaccines #WVCDC